Home › Funds › Point72 Asset Management › INBX
Point72 Asset Management position in INBX
INHIBRX BIOSCIENCES INC · Health Care
Latest position (Q2 2026)26.01K sh
Reported value held$2.46M
Portfolio Weight0.00%
First reportedQ2 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 699.10K | $7.93M | New |
| Q3 2022 | 457.10K | $8.21M | Reduce |
| Q4 2022 | 752.50K | $18.54M | Add |
| Q1 2023 | 239.12K | $4.51M | Reduce |
| Q2 2023 | 319.50K | $8.29M | Add |
| Q2 2026 | 26.01K | $2.46M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding INBX
- Morgan Stanley 1.31M sh · $123.94M · Q2 2026
- Viking Global Investors 1.12M sh · $106.49M · Q2 2026
- Bank of America Corp 841.14K sh · $79.70M · Q2 2026
- BlackRock Inc 825.97K sh · $78.26M · Q2 2026
- Vanguard Group 623.08K sh · $49.22M · Q4 2025
- Goldman Sachs Group 404.68K sh · $38.34M · Q2 2026
- Capital Research Global Investors 363.05K sh · $34.40M · Q2 2026
- Geode Capital Management 256.18K sh · $24.28M · Q2 2026
- Millennium Management 147.20K sh · $13.95M · Q2 2026
- Northern Trust Corp 100.96K sh · $9.57M · Q2 2026
- Norges Bank Investment Management 90.30K sh · $8.56M · Q2 2026
- Citigroup Inc 75.72K sh · $7.17M · Q2 2026